en

PRODUCT DETAIL

Xromi 100 mg/ml perorálny roztok

Code 2114D
MA number EU/1/19/1366/001
Product Form: sol por 1x150 ml/15 g (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX05 Hydroxycarbamide
Shelf life: 24
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 01.07.2019
Validity: 01.07.2024
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 09.03.2023
eu-flag.png sk-flag.png